首页> Frontiers in oncology> Postoperative ctDNA detection predicts relapse but has limited effects in guiding adjuvant therapy in resectable stage I NSCLC.

Postoperative ctDNA detection predicts relapse but has limited effects in guiding adjuvant therapy in resectable stage I NSCLC.

导出 LinkOut

翻译打印收藏纠错

第一作者： Bolin,Wang

第一单位： Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, China.;Department of Radiation Oncology and Shandong Provincial Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.;Research Unit of Radiation Oncology, Chinese Academy of Medical Sciences, Jinan, Shandong, China.

作者： Bolin,Wang ^[1] ; Bing,Zou ^[2] ; Shengnan,Xu ^[2] ; Chao,Zhao ^[2] ; Jinli,Pei ^[2] ; Shijie,Wang ^[2] ; Kunlong,Zhao ^[2] ; Jinming,Yu ^[2] ; Jie,Liu ^[2]

作者单位： Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, China.;Department of Radiation Oncology and Shandong Provincial Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.;Research Unit of Radiation Oncology, Chinese Academy of Medical Sciences, Jinan, Shandong, China. ^[1] Department of Radiation Oncology and Shandong Provincial Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.;Research Unit of Radiation Oncology, Chinese Academy of Medical Sciences, Jinan, Shandong, China. ^[2]

关键词 NSCLC adjuvant therapy circulating tumor DNA prognosis recurrence

DOI 10.3389/fonc.2023.1083417

PMID 36741027

发布时间 2023-02-07

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交